Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 3106 AL 3120

Olfaction in Parkin-associated Parkinson disease: another enigma

Markopoulou K, Chase BA.

Neurology. 2011 Jan 25;76(4):312-3. doi: 10.1212/WNL.0b013e31820882ee. Epub 2010 Dec 29.

Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study

Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, Ross B, Verbitsky M, Kisselev S, Comella C, Colcher A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, Rezak M, Novak KE, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Clark LN, Marder K.

Neurology. 2011 Jan 25;76(4):319-26. doi: 10.1212/WNL.0b013e31820882aa. Epub 2010 Dec 29.

A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesilate, a new anti-Parkinson drug

Zhang K, Xue N, Shi X, Liu W, Meng J, Du Y.

J Pharm Biomed Anal. 2011 Apr 28;55(1):220-4. doi: 10.1016/j.jpba.2010.12.030. Epub 2010 Dec 30.

Parkinson's disease, primates, and gene therapy: vive la différence?

Lewis TB, Standaert DG.

Mov Disord. 2011 Jan;26(1):2-3. doi: 10.1002/mds.23544. Epub 2010 Dec 17.

Why catechol?

Stern G.

Mov Disord. 2011 Jan;26(1):24-6. doi: 10.1002/mds.23117. Epub 2010 Nov 8.

Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains

Bartus RT, Herzog CD, Chu Y, Wilson A, Brown L, Siffert J, Johnson EM Jr, Olanow CW, Mufson EJ, Kordower JH.

Mov Disord. 2011 Jan;26(1):27-36. doi: 10.1002/mds.23442. Epub 2010 Nov 18.

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER)

Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P, Hill D, Anderson T, Myllyla V, Kassubek J, Steiger M, Zucconi M, Tolosa E, Poewe W, Surmann E, Whitesides J, Boroojerdi B, Chaudhuri KR; Recover Study Group.

Mov Disord. 2011 Jan;26(1):90-9. doi: 10.1002/mds.23441. Epub 2010 Nov 18.

Homeostatic changes of the endocannabinoid system in Parkinson's disease

Pisani V, Madeo G, Tassone A, Sciamanna G, Maccarrone M, Stanzione P, Pisani A.

Mov Disord. 2011 Feb 1;26(2):216-22. doi: 10.1002/mds.23457. Epub 2010 Dec 13.

Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease

Stathis P, Konitsiotis S, Tagaris G, Peterson D; VALID-PD Study Group.

Mov Disord. 2011 Feb 1;26(2):264-70. doi: 10.1002/mds.23355. Epub 2010 Dec 13.

Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease

Benincasa D, Pellicano C, Fanciulli A, Pontieri FE.

Mov Disord. 2011 Feb 1;26(2):355-7. doi: 10.1002/mds.23395. Epub 2010 Dec 13.

The most cited works in Parkinson's disease

Ponce FA, Lozano AM.

Mov Disord. 2011 Feb 15;26(3):380-90. doi: 10.1002/mds.23445. Epub 2010 Nov 10.

Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues

Rochester L, Baker K, Nieuwboer A, Burn D.

Mov Disord. 2011 Feb 15;26(3):430-5. doi: 10.1002/mds.23450. Epub 2010 Dec 13.

Instability of syllable repetition in Parkinson's disease--influence of levodopa and deep brain stimulation

Skodda S, Flasskamp A, Schlegel U.

Mov Disord. 2011 Mar;26(4):728-30. doi: 10.1002/mds.23439. Epub 2010 Nov 10.

Domestic violence and mistreatment in patients with parkinsonism: case reports, mechanisms, and discussion

Nazir T, Thomson AM.

Mov Disord. 2011 Mar;26(4):757-8. doi: 10.1002/mds.23438. Epub 2010 Dec 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias